Literature DB >> 30795981

Persistent Antibody Clonotypes Dominate the Serum Response to Influenza over Multiple Years and Repeated Vaccinations.

Jiwon Lee1, Philipp Paparoditis2, Andrew P Horton3, Alexander Frühwirth4, Jonathan R McDaniel1, Jiwon Jung5, Daniel R Boutz3, Dania A Hussein6, Yuri Tanno1, Leontios Pappas4, Gregory C Ippolito6, Davide Corti7, Antonio Lanzavecchia2, George Georgiou8.   

Abstract

Humans are repeatedly exposed to influenza virus via infections and vaccinations. Understanding how multiple exposures and pre-existing immunity impact antibody responses is essential for vaccine development. Given the recent prevalence of influenza H1N1 A/California/7/2009 (CA09), we examined the clonal composition and dynamics of CA09 hemagglutinin (HA)-reactive IgG repertoire over 5 years in a donor with multiple influenza exposures. The anti-CA09 HA polyclonal response in this donor comprised 24 persistent antibody clonotypes, accounting for 72.6% ± 10.0% of the anti-CA09 HA repertoire over 5 years. These persistent antibodies displayed higher somatic hypermutation relative to transient serum antibodies detected at one time point. Additionally, persistent antibodies predominantly demonstrated cross-reactivity and potent neutralization toward a phylogenetically distant H5N1 A/Vietnam/1203/2004 (VT04) strain, a feature correlated with HA stem recognition. This analysis reveals how "serological imprinting" impacts responses to influenza and suggests that once elicited, cross-reactive antibodies targeting the HA stem can persist for years.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  anti-hemagglutinin antibodies; humoral immunity; immunological imprinting; influenza vaccine response; longitudinal profiling; persistent antibodies; serum antibody repertoire

Mesh:

Substances:

Year:  2019        PMID: 30795981      PMCID: PMC6417944          DOI: 10.1016/j.chom.2019.01.010

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  56 in total

Review 1.  The evolution of human influenza viruses.

Authors:  A J Hay; V Gregory; A R Douglas; Y P Lin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

2.  Maintenance of serological memory by polyclonal activation of human memory B cells.

Authors:  Nadia L Bernasconi; Elisabetta Traggiai; Antonio Lanzavecchia
Journal:  Science       Date:  2002-12-13       Impact factor: 47.728

Review 3.  Influenza and the challenge for immunology.

Authors:  Peter C Doherty; Stephen J Turner; Richard G Webby; Paul G Thomas
Journal:  Nat Immunol       Date:  2006-05       Impact factor: 25.606

Review 4.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

Authors:  J J Skehel; D C Wiley
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

5.  Clonal dissection of the human memory B-cell repertoire following infection and vaccination.

Authors:  Debora Pinna; Davide Corti; David Jarrossay; Federica Sallusto; Antonio Lanzavecchia
Journal:  Eur J Immunol       Date:  2009-05       Impact factor: 5.532

6.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus.

Authors:  Jens Wrammert; Kenneth Smith; Joe Miller; William A Langley; Kenneth Kokko; Christian Larsen; Nai-Ying Zheng; Israel Mays; Lori Garman; Christina Helms; Judith James; Gillian M Air; J Donald Capra; Rafi Ahmed; Patrick C Wilson
Journal:  Nature       Date:  2008-04-30       Impact factor: 49.962

7.  Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Authors:  Rebecca J Garten; C Todd Davis; Colin A Russell; Bo Shu; Stephen Lindstrom; Amanda Balish; Wendy M Sessions; Xiyan Xu; Eugene Skepner; Varough Deyde; Margaret Okomo-Adhiambo; Larisa Gubareva; John Barnes; Catherine B Smith; Shannon L Emery; Michael J Hillman; Pierre Rivailler; James Smagala; Miranda de Graaf; David F Burke; Ron A M Fouchier; Claudia Pappas; Celia M Alpuche-Aranda; Hugo López-Gatell; Hiram Olivera; Irma López; Christopher A Myers; Dennis Faix; Patrick J Blair; Cindy Yu; Kimberly M Keene; P David Dotson; David Boxrud; Anthony R Sambol; Syed H Abid; Kirsten St George; Tammy Bannerman; Amanda L Moore; David J Stringer; Patricia Blevins; Gail J Demmler-Harrison; Michele Ginsberg; Paula Kriner; Steve Waterman; Sandra Smole; Hugo F Guevara; Edward A Belongia; Patricia A Clark; Sara T Beatrice; Ruben Donis; Jacqueline Katz; Lyn Finelli; Carolyn B Bridges; Michael Shaw; Daniel B Jernigan; Timothy M Uyeki; Derek J Smith; Alexander I Klimov; Nancy J Cox
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

8.  msmsEval: tandem mass spectral quality assignment for high-throughput proteomics.

Authors:  Jason W H Wong; Matthew J Sullivan; Hugh M Cartwright; Gerard Cagney
Journal:  BMC Bioinformatics       Date:  2007-02-09       Impact factor: 3.169

9.  Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses.

Authors:  Jianhua Sui; William C Hwang; Sandra Perez; Ge Wei; Daniel Aird; Li-mei Chen; Eugenio Santelli; Boguslaw Stec; Greg Cadwell; Maryam Ali; Hongquan Wan; Akikazu Murakami; Anuradha Yammanuru; Thomas Han; Nancy J Cox; Laurie A Bankston; Ruben O Donis; Robert C Liddington; Wayne A Marasco
Journal:  Nat Struct Mol Biol       Date:  2009-02-22       Impact factor: 15.369

10.  A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies.

Authors:  Nigel J Temperton; Katja Hoschler; Diane Major; Carolyn Nicolson; Ruth Manvell; Vo Minh Hien; Do Quang Ha; Menno de Jong; Maria Zambon; Yasuhiro Takeuchi; Robin A Weiss
Journal:  Influenza Other Respir Viruses       Date:  2007-05       Impact factor: 4.380

View more
  28 in total

Review 1.  How repertoire data are changing antibody science.

Authors:  Claire Marks; Charlotte M Deane
Journal:  J Biol Chem       Date:  2020-05-14       Impact factor: 5.157

2.  Understanding the Heterogeneous Population of Age-Associated B Cells and Their Contributions to Autoimmunity and Immune Response to Pathogens.

Authors:  Olivia Kugler-Umana; Priyadharshini Devarajan; Susan L Swain
Journal:  Crit Rev Immunol       Date:  2020       Impact factor: 2.214

Review 3.  Systems serology for decoding infection and vaccine-induced antibody responses to HIV-1.

Authors:  Srivamshi Pittala; Kyle S Morrison; Margaret E Ackerman
Journal:  Curr Opin HIV AIDS       Date:  2019-07       Impact factor: 4.283

4.  Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans.

Authors:  Haley L Dugan; Jenna J Guthmiller; Philip Arevalo; Min Huang; Yao-Qing Chen; Karlynn E Neu; Carole Henry; Nai-Ying Zheng; Linda Yu-Ling Lan; Micah E Tepora; Olivia Stovicek; Dalia Bitar; Anna-Karin E Palm; Christopher T Stamper; Siriruk Changrob; Henry A Utset; Lynda Coughlan; Florian Krammer; Sarah Cobey; Patrick C Wilson
Journal:  Sci Transl Med       Date:  2020-12-09       Impact factor: 17.956

Review 5.  Moving beyond Titers.

Authors:  Benjamin D Brooks; Alexander Beland; Gabriel Aguero; Nicholas Taylor; Francina D Towne
Journal:  Vaccines (Basel)       Date:  2022-04-26

6.  Original Antigenic Sin: Friend or Foe in Developing a Broadly Cross-Reactive Vaccine to Influenza?

Authors:  Priyadharshini Devarajan; Susan L Swain
Journal:  Cell Host Microbe       Date:  2019-03-13       Impact factor: 21.023

7.  Mass Spectrometry-Based De Novo Sequencing of Monoclonal Antibodies Using Multiple Proteases and a Dual Fragmentation Scheme.

Authors:  Weiwei Peng; Matti F Pronker; Joost Snijder
Journal:  J Proteome Res       Date:  2021-06-14       Impact factor: 4.466

8.  Impact of Immune Priming, Vaccination, and Infection on Influenza A(H3N2) Antibody Landscapes in Children.

Authors:  Michael Hinojosa; Samuel S Shepard; Jessie R Chung; Jennifer P King; Huong Q McLean; Brendan Flannery; Edward A Belongia; Min Z Levine
Journal:  J Infect Dis       Date:  2021-08-02       Impact factor: 5.226

9.  Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans.

Authors:  Jiwon Jung; Sophia T Mundle; Irina V Ustyugova; Andrew P Horton; Daniel R Boutz; Svetlana Pougatcheva; Ponraj Prabakaran; Jonathan R McDaniel; Gregory R King; Daechan Park; Maria D Person; Congxi Ye; Bing Tan; Yuri Tanno; Jin Eyun Kim; Nicholas C Curtis; Joshua DiNapoli; Simon Delagrave; Ted M Ross; Gregory C Ippolito; Harry Kleanthous; Jiwon Lee; George Georgiou
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

10.  Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma.

Authors:  Pavlo Gilchuk; Adrian Guthals; Stefano R Bonissone; Jared B Shaw; Philipp A Ilinykh; Kai Huang; Robin G Bombardi; Jenny Liang; Ariadna Grinyo; Edgar Davidson; Elaine C Chen; Bronwyn M Gunn; Galit Alter; Erica Ollmann Saphire; Benjamin J Doranz; Alexander Bukreyev; Larry Zeitlin; Natalie Castellana; James E Crowe
Journal:  Front Immunol       Date:  2021-07-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.